BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2240900)

  • 1. Gallium nitrate for advanced Paget disease of bone: effectiveness and dose-response analysis.
    Warrell RP; Bosco B; Weinerman S; Levine B; Lane J; Bockman RS
    Ann Intern Med; 1990 Dec; 113(11):847-51. PubMed ID: 2240900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone.
    Bockman RS; Wilhelm F; Siris E; Singer F; Chausmer A; Bitton R; Kotler J; Bosco BJ; Eyre DR; Levenson D
    J Clin Endocrinol Metab; 1995 Feb; 80(2):595-602. PubMed ID: 7852526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gallium to treat Paget's disease of bone: a pilot study.
    Matkovic V; Apseloff G; Shepard DR; Gerber N
    Lancet; 1990 Jan; 335(8681):72-5. PubMed ID: 1967419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with advanced Paget's disease of bone with two cycles of gallium nitrate.
    Bockman RS; Bosco B
    Semin Arthritis Rheum; 1994 Feb; 23(4):268-9. PubMed ID: 8009250
    [No Abstract]   [Full Text] [Related]  

  • 5. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
    Harinck HI; Papapoulos SE; Blanksma HJ; Moolenaar AJ; Vermeij P; Bijvoet OL
    Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1301-5. PubMed ID: 3120987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term treatment of Paget's disease of bone with ipriflavone.
    Agnusdei D; Camporeale A; Gonnelli S; Gennari C; Baroni MC; Passeri M
    Bone Miner; 1992 Oct; 19 Suppl 1():S35-42. PubMed ID: 1422319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paget's disease of bone treated with a five day course of oral tiludronate.
    Reginster JY; Lecart MP; Deroisy R; Ethgen D; Zegels B; Franchimont P
    Ann Rheum Dis; 1993 Jan; 52(1):54-7. PubMed ID: 8427515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD; Hawthorne AB; Kerr D; Webster G; Hosking DJ
    J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of response with oral clodronate in Paget's disease of bone.
    Khan SA; McCloskey EV; Nakatsuka K; Orgee J; Coombes GM; Kanis JA
    Bone; 1996 Feb; 18(2):185-90. PubMed ID: 8833213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
    Warrell RP; Israel R; Frisone M; Snyder T; Gaynor JJ; Bockman RS
    Ann Intern Med; 1988 May; 108(5):669-74. PubMed ID: 3282463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallium nitrate for the treatment of bone metastases.
    Warrell RP
    Cancer; 1997 Oct; 80(8 Suppl):1680-5. PubMed ID: 9362436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses.
    Kanis JA; Fitzpatrick K; Strong JA
    Q J Med; 1975 Jul; 44(175):399-413. PubMed ID: 1101286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of Paget's disease of bone with second-generation bisphosphonates via intravenous infusion].
    Arboleya L; Sánchez J; Iglesias G; Arranz JL
    Rev Clin Esp; 1993 Dec; 193(9):467-71. PubMed ID: 8108576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
    Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
    Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion.
    Warrell RP; Coonley CJ; Straus DJ; Young CW
    Cancer; 1983 Jun; 51(11):1982-7. PubMed ID: 6839291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
    Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mithramycin therapy in Paget's disease.
    Russell AS; Lentle BC
    Can Med Assoc J; 1974 Feb; 110(4):397-400. PubMed ID: 4273095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases.
    Warrell RP; Alcock NW; Bockman RS
    J Clin Oncol; 1987 Feb; 5(2):292-8. PubMed ID: 3806170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.